TITLE

Birth Control Pill Has Prevented 100,000 Deaths in Past 50 Years

PUB. DATE
May 2008
SOURCE
ONS Connect;May2008, Vol. 23 Issue 5, p8
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article discusses research being done on the prevention of ovarian cancer deaths by the use of contraceptive pill. It references a study by V. Beral et al published in the 2008 issue of "Lancet." The results of the study reveal that using oral contraceptives reduces women's risk of developing ovarian cancer. It shows that the longer use of oral contraceptives results to a bigger reduction in risk of ovarian cancer. It also shows that the risk reduction persisted for more than 30 years after women stopped taking the pill.
ACCESSION #
31944122

 

Related Articles

  • 4 must-know ovarian cancer facts. Bollinger, Caroline // Prevention;Sep2004, Vol. 56 Issue 9, p54 

    Focuses on facts about ovarian cancer. Experience of amateur rock climber Sean Patrick, who was diagnosed with stage 3 ovarian cancer; Comments of Patrick, who is raising awareness about ovarian cancer; Symptoms; Types of testing; Role of birth control pills in cutting risk; Risk factors,...

  • Biological Diversity of Ovarian Cancer Lessens Value of Screening.  // International Journal of Cancer Research;2011, Vol. 7 Issue 2, p164 

    No abstract available.

  • Risk of malignancy index is not sensitive in detecting non-epithelial ovarian cancer and borderline ovarian tumor. Meray, Onur; Türkçüoğlu, Ilgın; Meydanlı, Mehmet Mutlu; Kafkaslı, Ayşe // Journal of the Turkish-German Gynecological Association;Mar2010, Vol. 11 Issue 1, p22 

    Objective: To determine the value of risk of malignancy index in detection of ovarian cancer and referral of adnexal masses. Material and Method: Patients scheduled for surgery due to adnexal mass between May 2008 and August 2009 were prospectively included in the study. Risk of malignancy index...

  • Evidence shows Pill may offer protection from ovarian cancer.  // Practice Nurse;2/8/2008, Vol. 35 Issue 3, p6 

    The article focuses on a report published in "The Lancet," which reveals that the combined oral contraceptive pill gives women substantial and long-lasting protection against ovarian cancer. The research team estimated that, in high income countries, using oral contraceptives for 10 years...

  • Analysis of Perception, Attitude and Utilization of Oral Contraceptives among Population with History of Breast Cancer and Ovarian Cancer. LI Hong // Journal of International Obstetrics & Gynecology;Dec2013, Vol. 40 Issue 6, p568 

    Objective: To investigate the perception, attitude, and utilization of oral contraceptives (OC) among population with history of breast cancer and ovarian cancer. Methods; All of 92 females who had history of breast cancer and ovarian cancer among first level relatives were surveyed on...

  • Simple ultrasound rules to distinguish between benign and malignant adnexal masses before surgery: prospective validation by IOTA group. Timmerman, Dirk; Ameye, Lieveke; Fischerova, Daniela; Epstein, Elisabeth; Melis, Gian Benedetto; Guerriero, Stefano; Van Holsbeke, Caroline; Savelli, Luca; Fruscio, Robert; Lissoni, Andrea Alberto; Testa, Antonia Carla; Veldman, Joan; Vergote, Ignace; Van Huffel, Sabine; Bourne, Tom; Valentin, Lil // BMJ: British Medical Journal (Overseas & Retired Doctors Edition;1/8/2011, Vol. 342 Issue 7788, p94 

    The article discusses a study which examined the use of a simple ultrasound rules as a triage test to predict the benignity and malignancy in an adnexal mass. The study was conducted in 19 ultrasound centers in eight countries, where women with adnexal mass were examined using ultrasound based...

  • Angiogenesis-Related Gene Expression Profile with Independent Prognostic Value in Advanced Ovarian Carcinoma. Mendiola, Marta; Barriuso, Jorge; Redondo, Andrés; Mariño-Enríquez, Adrián; Madero, Rosario; Espinosa, Enrique; Fresno Vara, Juan Ángel; Sánchez-Navarro, Iker; Hernández-Cortes, Ginés; Zamora, Pilar; Pérez-Fernández, Elia; Miguel-Martín, María; Suárez, Asunción; Palacios, José; González-Barón, Manuel; Hardisson, David // PLoS ONE;2008, Vol. 3 Issue 12, p1 

    Background: Ovarian carcinoma is the most important cause of gynecological cancer-related mortality in Western societies. Despite the improved median overall survival in patients receiving chemotherapy regimens such as paclitaxel and carboplatin combination, relapse still occurs in most advanced...

  • Clinical Application of Serum Auto-fluorescent Spectrum in Diagnosis of Ovarian Cancer. QIAO Li-hua; YAN Su-qing; SHEN Yan-qin; NAI Ke-jun; MA Li-fang; JIANG Ling-yan; XIA Li-mei // Journal of International Obstetrics & Gynecology;Apr2014, Issue 41, p186 

    Objective:Using the technique of spectrum investigate the characteristics of the serum auto-fluorescent spectrum of patients with ovarian cancer. Methods:Using fluorospectrophotometer and 350 nm excitation light, the present study tested the serum auto-fluorescent spectrum of samples that been...

  • Oral Contraceptives and Reproductive Cancers: Weighting Risks and Benefits. Coker, Ann L.; Harlap, Susan; Fortney, Judith A. // Family Planning Perspectives;Jan/Feb93, Vol. 25 Issue 1, p17 

    The hypothetical incidence of reproductive cancers resulting from oral contraceptive use was estimated in several models comparing the cumulative lifetime incidence of cancer of the breast, cervix, ovary and endometrium expected in pill users with the incidence expected in nonusers. The...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics